STOCK TITAN

Inhibrx Inc - INBX STOCK NEWS

Welcome to our dedicated news page for Inhibrx (Ticker: INBX), a resource for investors and traders seeking the latest updates and insights on Inhibrx.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Inhibrx's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Inhibrx's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.59%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.79%
Tags
conferences
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.13%
Tags
none
Inhibrx Inc

Nasdaq:INBX

INBX Rankings

INBX Stock Data

1.66B
21.98M
19.57%
86.36%
3.38%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
La Jolla

About INBX

development of antibodies